Prevalence of diabetes mellitus in biopsy-positive giant cell arteritis

Journal of Neuro-Ophthalmology

Volumn 32, Issue 3, 2012, Pages 202-206

  Matthews, Jared L ^a   Gilbert, David N ^a   Farris, Bradley K ^a   Siatkowski, R Michael ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; BLOOD VESSEL BIOPSY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROSCOPY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEMPORAL ARTERY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES;

EID: 84865769876     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31825103cb     Document Type: Article

References (42)

1. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001;27:729-749.
2. Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med. 2002;69(suppl 2):SII-79-SII-82.
3. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine. 2005;84:269-276.
4. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, Vilaseca J, Urbano-Marquez A, Grau JM. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41:26-32.
5. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
6. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology. 1994;101:1779-1785.
7. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Arthritis Rheum. 1998;41:1497-1504.
8. Weyand CM, Goronzy JJ. Medium-and large-vessel vasculitis. N Engl J Med. 2003;349:160-169.
9. Walvick MD, Walvick MP. Giant cell arteritis: Laboratory predictors of a positive temporal artery biopsy. Ophthalmology. 2011;118:1201-1204.
10. Foroozan R, Danesh-Meyer H, Savino PJ, Gamble G, Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2002;109:1267-1271.
11. Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis. Rising platelet counts: A red flag for giant cell arteritis. J Neuroophthalmol. 2002;20:67-72.
12. Spranger J, Kroke A, Mohlig M, Hoffman K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 2003;52:812-817.
13. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-334.
14. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Ann Intern Med. 1967;67:968-976.
15. Arap A, Siqueira SR, Silva CB, Teixeira MJ, Siqueira JT. Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol. 2010;55:486-493.
16. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, Llorca J. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine. 2004;83:342-347.
17. Duhaut P, Pinede L, Domolombe-Rague S, Loire R, Seydoux D, Ninet J, Pasquier J. Giant cell arteritis and cardiovascular risk factors. Arthritis Rheum. 1998;41:1960-1965.
18. Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, Loire R, Pasquier J. Groupe de Recherche sur l'Artérite À Cellules Géantes. Biopsy proven and biopsy negative temporal arteritis: Differences in clinical spectrum at the onset of the disease. Ann Rheum Dis. 1999;58:335-341.
19. Rodriguez-Valverde V, Sarabia JM, Gonzalez-Gay MA, Figueroa M, Armona J, Blanco R, Fernandez-Sueiro JL, Martinez-Taboada VM. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997;102:331-336.
20. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92-101.
21. Rodriguez-Pla A, Rossello-Urgell J, Bosch-Gil JA, Huguet-Redecilla P, Vilardell-Tarres M. Proposal to decrease the number of negative temporal artery biopsies. Scand J Rheumatol. 2007;36:111-118.
22. Vilaseca J, Gonzalez A, Cid MC, Lopez-Vivancos J, Ortega A. Clinical usefulness of temporal artery biopsy. Ann Rheum Dis. 1987;46:282-285.
23. Chmelewski WK, McKnight KM, Agudelo CA, Wise CM. Presenting features and outcomes in patients undergoing temporal artery biopsy: A review of 98 patients. Arch Intern Med. 1992;152:1690-1695.
24. Gabriel SE, O'Fallon WM, Achkar AA, Lie JT, Hunder GG. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol. 1995;22:93-96.
25. Hedges TR, Geiger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol. 1983;101:1251-1254.
26. Jonasson F, Cullen JF, Elton RA. Temporal arteritis: A 14-year epidemiological, clinical, and prognostic study. Scott Med J. 1979;24:111-117.
27. Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, Llorca J, Gonzalez-Gay MA. Atherosclerosis in patients with biopsyproven giant cell arteritis. Arthritis Rheum. 2007;57:1481-1486.
28. Dare B, Byrne E. Giant cell arteritis: A five-year review of biopsyproven cases in a teaching hospital. Med J Aust. 1980;1:372-373.
29. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: New light on old controversies. Opthalmologica. 2003;217:239-259.
30. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M. Diabetes prevalence and diagnosis in US states: Analysis of health surveys. Popul Health Metr. 2009;7:16.
31. Seo P, Stone JH. Large-vessel vasculitis. Arthritis Rheum. 2004;51:128-139.
32. Lee MS, Grossman D, Arnold AC, Sloan FA. Incidence of nonarteritic anterior ischemic optic neuropathy: Increased risk among diabetic patients. Ophthalmology. 2011;118:959-963.
33. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-787.
34. Roth AM, Milsow L, Keltner JL. The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol. 1984;102:901-903.
35. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3:46-53.
36. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98-107.
37. Weyand CM, Tetzlaff N, Bjiirnsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997;40:19-26.
38. Breuer GS, Nesher R, Nesher G. Negative temporal artery biopsies: Eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol. 2008;26:1103-1106.
39. Brack A, Martinez-Taboada M, Stanson A, Goronzy JJ, Weyend CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311-317.
40. Ly K-H, Regent A, Tamby MC, Mouthon L. Pathogenesis of giant cell arteritis: More than just an inflammatory condition? Autoimmun Rev. 2010;9:635-645.
41. Casey J, Sturm C Jr. Impaired response of lymphocytes from non-insulin dependent diabetics to staphage lysate and tetanus antigen. J Clin Microbiol. 1982;15:109-114.
42. Ma-Krupa M, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant cell arteritis. Clin Immunol. 2005;115:38-46.